Evidence map›Paper›PMID 39320215›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration.

Daniel Palacios, Rakesh Kumar Majhi, Edina K Szabo, Dennis Clement, Mieszko Lachota, Herman Netskar, Leena Penna, Silje Z Krokeide, Marianna Vincenti, Lise Kveberg and 1 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel PalaciosDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Rakesh Kumar MajhiDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-6999-1349
Edina K SzaboDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-4780-5458
Dennis ClementDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Mieszko LachotaDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-2808-8916
Herman NetskarDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-3081-9581
Leena PennaFinnish Red Cross Blood Service, Research and Development, Helsinki, Finland.ORCID 0000-0003-4918-283X
Silje Z KrokeideDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0009-0002-3466-8706
Marianna VincentiDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-5361-0185
Lise KvebergDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-9308-0641
Karl-Johan MalmbergDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-8718-9373

Funding

Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FELICES, MARTIN · 2005 to 2025
$38.2M
Barncancerfonden (Swedish Childhood Cancer Foundation) PR2022-0150Cancerfonden (Swedish Cancer Society) 211793EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 801133Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)Kreftforeningen (NCS) 223310Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2021-073Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2024053Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2021-073Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2024053NCI NIH HHS P01 CA111412Norges Forskningsråd (Forskningsrådet) 275469Norges Forskningsråd (Forskningsrådet) 332727Norges Forskningsråd (Forskningsrådet) 237579Norges Forskningsråd (Forskningsrådet) 332727
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) represent the largest family of surface receptors and are responsible for key physiological functions, including cell growth, neurotransmission, hormone release, and cell migration. The GPCR 56 (GPR56), encoded by ADGRG1, is an adhesion GPCR found on diverse cell types, including neural progenitor cells, melanoma cells, and lymphocytes, such as effector memory T cells, γδ T cells, and NK cells. Using RNA-sequencing and high-resolution flow cytometry, we found that GPR56 mRNA and protein expression increased with NK cell differentiation, reaching its peak in adaptive NK cells. Small interfering RNA silencing of GPR56 led to increased spontaneous and chemokine-induced migration, suggesting that GPR56 functions as an upstream checkpoint for migration of highly differentiated NK cells. Increased NK cell migration could also be induced by agonistic stimulation of GPR56 leading to rapid internalization and deactivation of the receptor. Mechanistically, GPR56 ligation and downregulation were associated with transcriptional coactivator with PDZ-binding motif translocation to the nucleus and increased actin polymerization. Together, these data provide insights into the role of GPR56 in the migratory behavior of human NK cell subsets and may open possibilities to improve NK cell infiltration into cancer tissues by releasing a migratory checkpoint.

Indexed as

Cell MovementKiller Cells, NaturalReceptors, G-Protein-CoupledCell DifferentiationHumansADGRG1 protein, humanReceptors, G-Protein-Coupled

Identifiers

PMID39320215
PMCPMC11491499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.